Journal Logo

June 2011 - Volume 21 - e-Supplement Abstracts of the 7th European Association of Dermato-Oncology Congress (EADO)
pp: e1-e63

CO14. A pivotal study evaluating efficacy and safety of the hedgehog pathway inhibitor (HPI) vismodegib (GDC-0449) in patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC)

Sekulic, A.; Migden, M.R.; Oro, A.E.; More

Melanoma Research. 21:e9, June 2011.


Show: